Showing results (61-70 of 219) with videos related to
Sort By:
Pageof 22
Antiviral Therapy|November 30, 2005
Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?Amanda Mocroft, Jurgen Rockstroh, Vincent Soriano, et al.Parasitology International|April 19, 2021
PET/CT helps to determine treatment duration in patients with resected as well as inoperable alveolar echinococcosisLars Husmann, Urs J Muehlematter, Felix Grimm, et al.AIDS (London, England)|August 2, 2003
Virological rebound after suppression on highly active antiretroviral therapyAmanda Mocroft, Lidia Ruiz, Peter Reiss, et al.AIDS (London, England)|November 25, 2011
Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapyJustyna D Kowalska, Joanne Reekie, Amanda Mocroft, et al.AIDS Research and Human Retroviruses|December 16, 2004
Antiretroviral treatment and osteonecrosis in patients of the Swiss HIV Cohort Study: a nested case-control studyBarbara Hasse, Bruno Ledergerber, Matthias Egger, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2005
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapyGilbert R Kaufmann, Hansjakob Furrer, Bruno Ledergerber, et al.HIV Clinical Trials|April 19, 2011
A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA studyJustyna D Kowalska, Amanda Mocroft, Bruno Ledergerber, et al.AIDS (London, England)|August 19, 2004
Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppressionAndrew N Phillips, Bruno Ledergerber, Andrezej Horban, et al.JAMA|December 13, 2012
Effect of acetazolamide and autoCPAP therapy on breathing disturbances among patients with obstructive sleep apnea syndrome who travel to altitude: a randomized controlled trialTsogyal D Latshang, Yvonne Nussbaumer-Ochsner, Rahel M Henn, et al.AIDS (London, England)|July 20, 2002
Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 x 10(6) /lMilos Opravil, Bruno Ledergerber, Hansjakob Furrer, et al.Pageof 22